Drug Research Unit Maastricht
description
Transcript of Drug Research Unit Maastricht
![Page 1: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/1.jpg)
The Early Phase (0-I-II) Clinical Drug Research Unit of Maastricht University Medical Center (MUMC)
prof dr L. Van Bortel
Drug Research Unit Maastricht
![Page 2: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/2.jpg)
Mission Statement
To contribute to the development of new drugs
by conducting early phase clinical trials (phase 0-I-II)
in compliance with (inter)national legislation and quality standards
![Page 3: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/3.jpg)
• essential part in chain of drug developmentpreclinical → early phase → phase 3&4
• by filling the gap in the drug research chain • facilitates translational research
Position in MUMC-holding/valorisation chain
![Page 4: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/4.jpg)
Close collaboration with Drug Research Unit Ghent (DRUG): 1 CEO for 2 units• ↑ possibilities of conducting larger trials or trials with difficult recruitment• DRUM can take advantage of the elaborated quality management
system and training at DRUG• Joint PR for internal and external sponsors• Cross-fertilisation of know-how/methods …
Strategic alliance
![Page 5: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/5.jpg)
sponsors
•Pharmaceutical industry (+ nutriceuticals)
•Non for profit organisations
•MUMC
•Other University departments
![Page 6: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/6.jpg)
What can DRUM offer sponsors
State of the art conduct of early phase clinical studies• High quality• Large expertise• Short timelines• High flexibility• Fair cost
![Page 7: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/7.jpg)
What can DRUM offer sponsors
State of the art conduct of early phase clinical studies• High quality• Large expertise• Short timelines• High flexibility• Fair cost
![Page 8: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/8.jpg)
Quality
quality control– first party (internal) audits
• scheduled on main procedures• ad hoc for (near) errors
– training in SOP (all SOP’s revised within 2 yrs)– close feedback on the spot / approval system
quality assurance– 1 GCP-ICH third party audit/yr– ISO 9001:2008 → 1 ISO audit/yr (within 1
year?)
![Page 9: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/9.jpg)
What can DRUM offer sponsors
State of the art conduct of early phase clinical studies• High quality• Large expertise• Short timelines• High flexibility• Fair cost
![Page 10: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/10.jpg)
Large expertise
takes advantage of experts in 2 knowledge centers: MUMC - U(Z)Gent→ many therapeutic areas→ high tec investigations
experience in early phase clinical drug research– principal investigator: 24 years– investigator: 4 years
![Page 11: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/11.jpg)
What can DRUM offer sponsors
State of the art conduct of early phase clinical studies• High quality• Large expertise• Short timelines• High flexibility• Fair cost
![Page 12: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/12.jpg)
Timelines (cfr DRUG)
EC: Ethics Committee www.drug-uzgent.be
Number of working days Median 2005
Median 2006
Median 2007
Median 2008
Median 2009
From submission EC to final answer EC
14,5 11 11 14 14.5
From submission EC to first dosing
23 24 24 22 18.5
From last monitoring visit to release of study data to monitor
1 3 3 3 1
![Page 13: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/13.jpg)
What can DRUM offer sponsors
State of the art conduct of early phase clinical studies• High quality• Large expertise• Short timelines• High flexibility• Fair cost
![Page 14: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/14.jpg)
High flexibility
•Dose adjustments•Pharmacy with GMPz•Pharmacell bv with full GMP
•Additional safety measures•Puts pressure on working hours/social environment of staff, particularly in the early years
![Page 15: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/15.jpg)
What can DRUM offer the MUMC
• Service center for early phase drug investigations
• Take advantage of knowledge center (experts in MUMC)
• Facilitates education (training) in Medicine/ Health Sciences/clinical pharmacologist
![Page 16: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/16.jpg)
staff
•Principal investigator - investigator - quality coordinator - managing coordinator - clinical research coordinator - trial nurse - office manager•investigator/principal investigator experienced in early phase studies•All are well-trained
training at DRUG•Highly motivated•Bank personnel: trial nurses / co-investigators
![Page 17: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/17.jpg)
facilities
• 16 beds for clinical research and overnight stay• 2 sample handling laboratories (temperature controlled)• 1 drug storage room (temperature controlled / alarm)• 1 freezer (-18°C) + 1 (-70°C) temperature controlled / alarm)• 2 refrigerators (temperature controlled / alarm) • offices, archive, meeting room, reception, kitchen, storage room
![Page 18: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/18.jpg)
facilities
• 16 beds for clinical research and overnight stay• 2 sample handling laboratories (temperature controlled)• 1 drug storage room (temperature controlled / alarm)• 1 freezer (-18°C) + 1 (-70°C) temperature controlled / alarm)• 2 refrigerators (temperature controlled / alarm) • offices, archive, meeting room, reception, kitchen, storage room
![Page 19: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/19.jpg)
facilities
• 16 beds for clinical research and overnight stay• 2 sample handling laboratories (temperature controlled)• 1 drug storage room (temperature controlled / alarm)• 1 freezer (-18°C) + 1 (-70°C) temperature controlled / alarm)• 2 refrigerators (temperature controlled / alarm) • offices, archive, meeting room, reception, kitchen, storage room
![Page 20: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/20.jpg)
Ready to start!
![Page 21: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/21.jpg)
Summary
•Centre of Excellence (qualified staff / approval / external audits / ISO 9001:2008)
• short timelines, high flexibility
• takes advantage of university knowledge centre
![Page 22: Drug Research Unit Maastricht](https://reader036.fdocuments.in/reader036/viewer/2022062521/56816797550346895ddccf91/html5/thumbnails/22.jpg)
YES, we can!